Search

Electroencephalography (EEG) is crucial for epilepsy detection; however, detecting abnormalities takes experience and knowledge. The electroencephalogram (EEG) is a technology that measures brain motion and represents the brain’s function. EEG is an effective instrument for deciphering the brain’s complicated activity. The information contained in the EEG signal pertains to the electric functioning of the brain. Neurologists have typically used direct visual inspection to detect epileptogenic abnormalities. This method is time-consuming, restricted by technical artifacts, produces varying findings depending on the reader’s level of experience, and is ineffective at detecting irregularities. As a result, developing automated algorithms for detecting anomalies in EEGs associated with epilepsy is critical. The construction of a novel class of convolutional neural networks (CNNs) for detecting aberrant waveforms and sensors in epilepsy EEGs is described in this research. In this study, EEG signals are analyzed using a convolutional neural network (CNN). For the automatic detection of abnormal and normal EEG indications, a novel deep one-dimensional convolutional neural network (1D CNN) model is suggested in this paper. The regular, pre-ictal, and seizure categories are detected using this approach. The proposed model achieves an accuracy of 85.48% and a reduced categorization error rate of 14.5%.

All organisms contain antimicrobial peptides (AMPs), which are a critical component of the innate immune system. These chemicals have the ability to suppress the growth of a variety of fungi, bacteria, and viruses. Because AMPs interact with structural components of the microbial cell membrane and have a wide range of cellular targets, bacteria are unlikely to be able to develop resistance to them in the short term. The underlying structure of AMPs is critical in determining the selectivity with which they target their respective targets. As far as we know, peptides have not been tested in a lab to see if they can fight bacteria, fungus, and viruses in real life. In this paper, we develop an artificial neural network (ANN) using a back propagation neural network (BPNN) that enables optimal classification of tendency of a peptide sequence that involves the activities of antifungal, antibacterial, or antiviral. The BPNN is trained on the datasets collected across different repositories and then the overfitting is avoided using particle swarm optimization (PSO) algorithm. Hence, at the time of testing, the BPNN clearly finds the predicted samples belonging to the same classes and this avoids the problem of finding the false positives. The simulation is conducted to test the efficacy of the model against various metrics that includes accuracy, precision, recall, and f1-measure. The effectiveness of the BPNN-PSO model in classifying instances at a faster rate than other techniques is demonstrated by its performance. The principle is straightforward, it is not difficult to programme, it converges more quickly, and it generally offers a superior solution.

Stroke-related disabilities can have a major negative effect on the economic well-being of the person. When left untreated, a stroke can be fatal. According to the findings of this study, people who have had strokes generally have abnormal biosignals. Patients will be able to obtain prompt therapy in this manner if they are carefully monitored; their biosignals will be precisely assessed and real-time analysis will be performed. On the contrary, most stroke diagnosis and prediction systems rely on image analysis technologies such as CT or MRI, which are not only expensive but also hard to use. In this study, we develop a machine learning algorithm for the prediction of stroke in the brain, and this prediction is carried out from the real-time samples of electromyography (EMG) data. The study uses synthetic samples for training the support vector machine (SVM) classifier and then the testing is conducted in real-time samples. To improve the accuracy of prediction, the samples are generated using the data augmentation principle, which supports training with vast data. The simulation is conducted to test the efficacy of the model, and the results show that the proposed classifier achieves a higher rate of classification accuracy than the existing methods. Furthermore, it is seen that the rate of precision, recall, and f-measure is higher in the proposed SVM than in other methods.